New device could make GERD diagnosis quicker and less painful

NCT ID NCT03103789

ENROLLING_BY_INVITATION Diagnosis Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new, less invasive device that measures the health of the esophagus in people with acid reflux (GERD). Researchers will compare two versions of the device in 75 patients undergoing routine endoscopy. The goal is to see if this technology can diagnose GERD more accurately and comfortably than current methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mucosal impedance testing device
What this could lead to: If successful, this could provide a more accurate and less invasive way to diagnose GERD, potentially replacing more uncomfortable tests.
What could go wrong: This is an early-stage study with only 75 participants. The new device may not prove more accurate than existing methods, and results may not apply to all GERD patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRO ESOPHAGEAL REFLUX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroesophageal reflux disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRO ESOPHAGEAL REFLUX

Contacts and locations

Locations

Vanderbilt University Medical Center Endoscopy Laboratory

Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.